Clinical Trial Update: Uromune in Treating Recurrent Urinary Tract Infections in Women [Phase 2]

View source ↗

Summary

Phase 2 trial of Uromune for recurrent urinary tract infections in women was terminated, with results posted on 2024-05-30.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Uromune

Snippet

Sponsor: Queen's University | Conditions: Recurrent Uti | Phase 2 | Status: TERMINATED | Results posted: 2024-05-30